Search results

  1. Arfmeister

    News from The Netherlands

    Ah, ok. Well Rosmalen already gets Long Covid funding through the Lifelines project.
  2. Arfmeister

    News from The Netherlands

    Did they really apply for funding? Specially Knoop?
  3. Arfmeister

    CAR-T therapy

    @siobhanfirestone Do you know more details about patient history / anamnesis and clinical picture & Symptoms? Typical ME CFS (strict guidelines e.g. with PEM)? How long sick ? Measurements e.g. antibodies, etc? Why was decided on Car-T ? Which clinic was giving access to Car-T based on what...
  4. Arfmeister

    Rapamycin Pilot Treatment Trial for ME/CFS

    I agree with all the criticism. If I would be a RA patient I would be very disappointed with this trial. Unfortunately in the world of ME CFS patients, this is as good as it gets. Maybe there is 1, maybe 2 double blind controlled trials taking place for ME CFS at this moment. So, although...
  5. Arfmeister

    ME conference in Sweden 11-12th Oct 2023, The Hidden Disease

    Has anyone seen Prusty Presentation? I found it very interesting. Maybe it is A repetition of Findings and Hypothesis he has mentioned before, but for me, it was very clarifying. Specifically this slide, which IF it is a valid model of disease mechanism, is very good. – It’s the second part of...
  6. Arfmeister

    Efficacy of daratumumab in refractory primary Sjögren disease Nocturne 2023

    Quick search, but Can t find the YouTube link. From this conference. https://mecfs-research.org/mecfs-conference2023/ B and Plasma Cell Targeting in ME/CFS Øystein Fluge
  7. Arfmeister

    Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study,2023

    Indeed. Every patient has to be well informed on possible risks. Therefore - by lack of doctors that are treating us - we should be able to asses and check the research data ourselves. I did a quick search and found various studies. I have not found your 40%, do you possibly have a link? - to...
  8. Arfmeister

    Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study,2023

    I agree completely. One should understand that a lot of patients are already progressively severely (and violently) ill, and don’t have any choices. If we would have a plethora of options similar to diseases like Rheuma or M.S. there would be a choice. But for us it is basically choose CGT/GET...
  9. Arfmeister

    Immune adsorption for the treatment of fatigue-dominant long-/post-COVID syndrome—a case series [...], 2023, Ruhe et al

    Very Similar study Preprint With Scheibenbogen involved. 10 patients with 7 responders What is mostly (temporarily) help earlier stage ME CFS? Or also benefit for late stage, more severe ME CFS? there is the anecdotal improvement of the (very) severe German patient Faraz Fallahi - you can...
  10. Arfmeister

    The itaconate shunt hypothesis

    Question from Robert Phair on PhRising An ACOD1 genomics question https://forums.phoenixrising.me/threads/an-acod1-genomics-question.90574/
  11. Arfmeister

    Muscle abnormalities worsen after post-exertional malaise in long COVID, 2023/4, Wüst, van Vugt, Appelman et al

    At quick glance I can only find Publications on Amyloid deposition in skeletal muscle in relation to Amyloidosis https://www.sciencedirect.com/science/article/abs/pii/S0046817798900612 https://jnnp.bmj.com/content/jnnp/60/6/655.full.pdf and many more
Back
Top Bottom